Startups
Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives.
Overview
Location
Canada, Nova Scotia, Halifax
Employees
11-50
Total raised
$44.2M
Founded date
2015
Funding Rounds 8
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 26, 2022 | Funding round | $4.5M | |
| Mar 2, 2022 | Funding round | $10M | |
| Jul 2, 2019 | Grant | $3M | |
| Feb 7, 2018 | Funding round | $4.3M | |
| Oct 24, 2017 | Funding round | $3M | |
| Dec 22, 2016 | Funding round | $2.2M | |
| May 25, 2016 | Seed round | $3.2M |
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 30, 2021 | Как нам обуздать строптивый коронавирус | Новое – это хорошо забытое старое. Жак Пеше Для начала хочу предложить читателям медико-философское правило, которое звучит так: Правило это основано на законах эволюции и подтверждено практикой. Ибо те, кто использует даже слегка вредные п... |
| Aug 24, 2021 | Funding roundup: Figment, FIX4 Capital, Highstreet, Appili Therapeutics, Viridis Terra | Five tech companies with Canadian roots have recently secured fresh funding to fuel their growth. Here are the details on who raised money, how much, from whom, and what they plan to put the new capital toward. Figment secures $50 million t... |
| Aug 19, 2021 | Appili Therapeutics : Announces Closing of $3.5 Million Funding Agreement | HALIFAX, Nova Scotia - Appili Therapeutics Inc. (TSX: APLI) (the 'Company' or 'Appili'), a biopharmaceutical company focused on drug development for infectious diseases, announced that it has closed its $3.5 million convertible security fun... |
| Aug 9, 2021 | Appili Therapeutics : Secures $3.5 Million in Funding | Appili Therapeutics Inc. (TSX: APLI) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, today announced that it has entered into a $3.5 million convertible security funding agreemen... |
| May 17, 2021 | Independent Data Safety Monitoring Board Recommends Appili Therapeutics Complete Its Phase 3 Avigan®/Reeqonus™ Trial for Mild-to-Moderate COVID-19 Patients | |
| Feb 21, 2020 | Today in funding: ClaroNav, Appili Therapeutics | Two Canadian healthtech companies have announced fresh funding to fuel their growth. Here’s the latest on who raised. ClaroNav raises $2 million in first external financing round Toronto-based healthtech startup ClaroNav, which develops sur... |
| Feb 8, 2018 | Term Sheet — Thursday, February 8 | ARMED WITH DATA Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Ohanian said he will return to Initialized Capital, an early-stage VC firm he co-founded with Garry Tan, as a full-time general... |
| Feb 7, 2018 | Appili Therapeutics Raises $4.3M in Financing | Appili Therapeutics Inc., a Halifax, Canada-based biopharmaceutical company developing and commercializing anti-infective drugs, raised an additional $4.33m in financing. This brings the total equity raised since its seed round in March 201... |
| Feb 7, 2018 | Halifax-based Appili Therapeutics raises $4.3 million to develop solutions for antibiotic resistance | Halifax-based Appili Therapeutics, which is developing and commercializing anti-infective drugs, has raised $4.3 million. The company said the funding includes new and existing investors, though it only named Innovacorp, Nova Scotia’s early... |
Show more
Reviews 0
FAQ about Appili Therapeutics
When was Appili Therapeutics founded?
Appili Therapeutics was founded in 2015.
How much funding has Appili Therapeutics raised?
Appili Therapeutics has raised $44.2M in total across 8 funding rounds.
What funding rounds has Appili Therapeutics raised?
Parsers VC lists 8 funding rounds of Appili Therapeutics, among them a funding round of $4.5M on May 26, 2022, a funding round of $10M on Mar 2, 2022 and a grant of $3M on Jul 2, 2019.
What has the press written about Appili Therapeutics?
Parsers VC has collected 17 articles mentioning Appili Therapeutics, among them “Как нам обуздать строптивый коронавирус” (Nov 30, 2021) and “Funding roundup: Figment, FIX4 Capital, Highstreet, Appili Therapeutics, Viridis Terra” (Aug 24, 2021).
Is Appili Therapeutics still active?
Yes, Appili Therapeutics is active; its latest activity on Parsers VC dates from Mar 1, 2022.